• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Intensive Care . Factors influencing liberation from mechanical ventilation in coronavirus disease 2019: multicenter observational study in fiftee

tetano

Editor, Senior Moderator
J Intensive Care


. 2020 Oct 15;8(1):80.
doi: 10.1186/s40560-020-00499-4.
Factors influencing liberation from mechanical ventilation in coronavirus disease 2019: multicenter observational study in fifteen Italian ICUs


Lorenzo Gamberini[SUP] 1 [/SUP], Tommaso Tonetti[SUP] 2 [/SUP], Savino Spadaro[SUP] 3 [/SUP], Gianluca Zani[SUP] 4 [/SUP], Carlo Alberto Mazzoli[SUP] 1 [/SUP], Chiara Capozzi[SUP] 5 [/SUP], Emanuela Giampalma[SUP] 6 [/SUP], Maria Letizia Bacchi Reggiani[SUP] 7 [/SUP], Elisabetta Bertellini[SUP] 8 [/SUP], Andrea Castelli[SUP] 5 [/SUP], Irene Cavalli[SUP] 9 [/SUP], Davide Colombo[SUP] 10 11 [/SUP], Federico Crimaldi[SUP] 12 [/SUP], Federica Damiani[SUP] 13 [/SUP], Alberto Fogagnolo[SUP] 3 [/SUP], Maurizio Fusari[SUP] 4 [/SUP], Emiliano Gamberini[SUP] 14 [/SUP], Giovanni Gordini[SUP] 1 [/SUP], Cristiana Laici[SUP] 15 [/SUP], Maria Concetta Lanza[SUP] 16 [/SUP], Mirco Leo[SUP] 17 [/SUP], Andrea Marudi[SUP] 8 [/SUP], Giuseppe Nardi[SUP] 18 [/SUP], Irene Ottaviani[SUP] 3 [/SUP], Raffaella Papa[SUP] 19 [/SUP], Antonella Potalivo[SUP] 18 [/SUP], Emanuele Russo[SUP] 14 [/SUP], Stefania Taddei[SUP] 20 [/SUP], Carlo Alberto Volta[SUP] 3 [/SUP], V Marco Ranieri[SUP] 9 [/SUP], ICU-RER COVID-19 Collaboration



Collaborators, Affiliations

Abstract

Background: A large proportion of patients with coronavirus disease 2019 (COVID-19) develop severe respiratory failure requiring admission to the intensive care unit (ICU) and about 80% of them need mechanical ventilation (MV). These patients show great complexity due to multiple organ involvement and a dynamic evolution over time; moreover, few information is available about the risk factors that may contribute to increase the time course of mechanical ventilation. The primary objective of this study is to investigate the risk factors associated with the inability to liberate COVID-19 patients from mechanical ventilation. Due to the complex evolution of the disease, we analyzed both pulmonary variables and occurrence of non-pulmonary complications during mechanical ventilation. The secondary objective of this study was the evaluation of risk factors for ICU mortality.
Methods: This multicenter prospective observational study enrolled 391 patients from fifteen COVID-19 dedicated Italian ICUs which underwent invasive mechanical ventilation for COVID-19 pneumonia. Clinical and laboratory data, ventilator parameters, occurrence of organ dysfunction, and outcome were recorded. The primary outcome measure was 28 days ventilator-free days and the liberation from MV at 28 days was studied by performing a competing risks regression model on data, according to the method of Fine and Gray; the event death was considered as a competing risk.
Results: Liberation from mechanical ventilation was achieved in 53.2% of the patients (208/391). Competing risks analysis, considering death as a competing event, demonstrated a decreased sub-hazard ratio for liberation from mechanical ventilation (MV) with increasing age and SOFA score at ICU admission, low values of PaO[SUB]2[/SUB]/FiO[SUB]2[/SUB] ratio during the first 5 days of MV, respiratory system compliance (C[SUB]RS[/SUB]) lower than 40 mL/cmH[SUB]2[/SUB]O during the first 5 days of MV, need for renal replacement therapy (RRT), late-onset ventilator-associated pneumonia (VAP), and cardiovascular complications. ICU mortality during the observation period was 36.1% (141/391). Similar results were obtained by the multivariate logistic regression analysis using mortality as a dependent variable.
Conclusions: Age, SOFA score at ICU admission, C[SUB]RS[/SUB], PaO[SUB]2[/SUB]/FiO[SUB]2[/SUB], renal and cardiovascular complications, and late-onset VAP were all independent risk factors for prolonged mechanical ventilation in patients with COVID-19.
 
Back
Top Bottom